ABVC BioPharma Submitted Vitargus® Phase II Study Plan to Australia HREC
June 16, 2022 08:30 ET
|
ABVC BioPharma, Inc.
FREMONT, CA, June 16, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – ABVC Biopharma, Inc. (NASDAQ: ABVC), a clinical stage biopharmaceutical company developing therapeutic solutions in...